Carl Sadowsky - Concepedia

Author

Carl Sadowsky

Also Known As

Athena Lee, Bruce L. Miller, Bryan M. Spann, C H Sadowsky, C Sadowsky, C. H. Sadowsky, C. Sadowsky, CARL H. SADOWSKY, Carl H Sadowsky, Carl H. Sadowsky

206

Publications

15.5K

Citations

H-Index

Concepts

All Affiliations

Nova Southeastern University Premiere Research Institute Palm Beach Neurology Banner Alzheimer’s Institute Banner Sun Health Research Institute

About

Carl Sadowsky is an author at Nova Southeastern University specializing in medicine, neurology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	1.7K
2	Health Sciences	3	3	105
3	Social Sciences	2	2	182
4	Anesthesia	1	1	16
5	Cognitive Science	1	1	69

Carl Sadowsky

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study Christopher M. Clark, Michael J. Pontecorvo, Thomas G. Beach, The Lancet Neurology Cerebral PetDementiaNeuritic Amyloid-β PlaquesNeurologyNeuroscience	2012	823
Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects Abhinay D. Joshi, Michael J. Pontecorvo, Chrisopher M. Clark, Journal of Nuclear Medicine	2012	387
Phase 3 Trial of Flutemetamol Labeled With Radioactive Fluorine 18 Imaging and Neuritic Plaque Density Craig Curtis, José E. Gámez, Upinder Singh, JAMA Neurology	2015	329
A six‐month double‐blind, randomized, placebo‐controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patch <i>versus</i> capsule Bengt Winblad, Jeffrey L. Cummings, Niels Andreasen, International Journal of Geriatric Psychiatry	2007	283
Florbetapir (F18‐AV‐45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging Keith A. Johnson, Reisa A. Sperling, Christopher Gidicsin, Alzheimer s & Dementia	2013	244
Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline P. Murali Doraiswamy, Reisa A. Sperling, Robert E. Coleman, Neurology	2012	228
Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease Adam Fleisher, Kewei Chen, Xiaofen Liu, Neurobiology of Aging Neurodegenerative DiseasesAlzheimer's DiseaseAgingBiomarkersDegenerative Pathology	2012	206
Effects of a combined transcranial magnetic stimulation (TMS) and cognitive training intervention in patients with Alzheimer's disease Marwan N. Sabbagh, Carl Sadowsky, Babak Tousi, Alzheimer s & Dementia	2019	158
Vascular burden and Alzheimer disease pathologic progression Raymond Y. Lo, William J. Jagust, Michael W. Weiner, Neurology	2012	153
Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients With Late-Life Depression Junhao Wen, Cynthia H.Y. Fu, Duygu Tosun, JAMA Psychiatry	2022	134

Page 1